MyMD Pharmaceuticals, Inc. - Enterprise Value

The Enterprise Value as of July 2026 (TTM) for MyMD Pharmaceuticals, Inc. (MYMD) is 4.58M

According to MyMD Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.58M. This represents a change of -67.33% compared to the average of 14.01M of the last 4 quarters.

MyMD Pharmaceuticals, Inc. (MYMD) Historical Enterprise Value (quarterly & annually)

How has MYMD Enterprise Value performed in the past?

The mean historical Enterprise Value of MyMD Pharmaceuticals, Inc. over the last ten years is 1.06M. The current 4.58M Enterprise Value has changed 43.17% with respect to the historical average. Over the past ten years (40 quarters), MYMD's Enterprise Value was at its highest in in the December 2025 quarter at 29.70M. The Enterprise Value was at its lowest in in the December 2023 quarter at -2567150.40.

MyMD Pharmaceuticals, Inc. (MYMD) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of MyMD Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

MyMD Pharmaceuticals, Inc. (MYMD) Average Enterprise Value

How has MYMD Enterprise Value performed in the past?

The current Enterprise Value of MyMD Pharmaceuticals, Inc. (MYMD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

MyMD Pharmaceuticals, Inc. (MYMD) Enterprise Value vs. Peers

How is MYMD’s Enterprise Value compared to its peers?

MyMD Pharmaceuticals, Inc.’s Enterprise Value is less than Gamida Cell Ltd. (40.73M), greater than Aptose Biosciences Inc. (3.42M), greater than Hillstream BioPharma, Inc. (-37360300.00), greater than Nabriva Therapeutics plc (-7192677.00), greater than VivoSim Labs, Inc. (-3501002.00), greater than Altamira Therapeutics Ltd. (495.99K), less than Gritstone bio, Inc. (43.29M), greater than Onconetix, Inc. (-3151845.00), less than Unity Biotechnology, Inc. (19.40M), greater than Neuphoria Therapeutics Inc. (266.14K),

Build a custom stock screener for MyMD Pharmaceuticals, Inc. (MYMD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MyMD Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MyMD Pharmaceuticals, Inc. (MYMD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MyMD Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.